Literature DB >> 6748379

Determination of chlorpromazine in the blood and brain of mice by high performance liquid chromatography combined with electrochemical detection.

S Shibanoki, Y Gotoh, K Ishikawa.   

Abstract

A simple and sensitive procedure was developed for determining the concentration of chlorpromazine (CPZ) in the blood and brain of mice with promethazine as the internal standard. The procedure involves (1) primary extraction by a mixture of heptane and isoamyl alcohol (99:1) in an alkaline condition and (2) determination by means of high performance liquid chromatography with electrochemical detection. The detection limit of CPZ was 0.5 ng for one chromatographic injection. The drug was detectable in a 100 microliters sample of the blood by 6 hr after an intravenous injection of 0.25 mg/kg. The concentration of CPZ was about 40 times higher in the brain compared with that in the blood. The biological half life was estimated to be 87 and 65 min, in the blood and brain, respectively. The proposed method is also applicable for the determination of other phenothiazine derivatives and effective for pharmacokinetic study of the compounds in clinics and laboratories.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6748379     DOI: 10.1254/jjp.35.169

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain.

Authors:  C N Svendsen; E D Bird
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Chlorpromazine inhibits nitric oxide-mediated increase in intracellular cGMP in a mouse teratocarcinoma cell line.

Authors:  M Fratelli; R Delgado; M Zinetti; G Galli; Y Rolland; P Ghezzi
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

3.  Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice.

Authors:  M Mengozzi; G Fantuzzi; R Faggioni; A Marchant; M Goldman; S Orencole; B D Clark; M Sironi; F Benigni; P Ghezzi
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

4.  Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock.

Authors:  M Gadina; R Bertini; M Mengozzi; M Zandalasini; A Mantovani; P Ghezzi
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.